Hypothalmic-pituitary-adrenal function in thyrd disorders: effects of methopyrapone infusion on plasma corticosteroids.
D015065:17-Hydroxycorticosteroids / Q000097:blood*; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000097:blood; D000324:Adrenocorticotropic Hormone; D000328:Adult; D002855:Chromatography, Thin Layer; D006801:Humans; D006980:Hyperthyroidism / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007263:Infusions, Parenteral; D008797:Metyrapone; D008875:Middle Aged; D009230:Myxedema / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000502:physiology*; D013959:Thyroid Diseases / Q000503:physiopathology*; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone